Immunization with a plasmid-DNA vaccine encoding murine Foxl2-tt confirms immunogenicity of FOXL2 and controls tumor growth of FoxL2-expressing tumors without affecting female reproductive organs. Here, FOXL2 is linked to neoplasm.